Rapid improvement of severe Mpox lesions with oral tecovirimat

Affiliations

¹ Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy.
² Tropical and Infectious Diseases Unit, University Hospital of Padova, Padova, Italy.
³ UOC Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
⁴ Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
⁵ Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, Italy.
⁶ Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.

Comment

Angelo Roberto Raccagni et al. J Med Virol. 2023 Jun.

. 2023 Jun;95(6):e28825.

doi: 10.1002/jmv.28825.

¹ Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy.
² Tropical and Infectious Diseases Unit, University Hospital of Padova, Padova, Italy.
³ UOC Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
⁴ Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
⁵ Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, Italy.
⁶ Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.

No abstract available

Comment on

Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern-A first case-series experience.
Hermanussen L, Grewe I, Tang HT, Nörz D, Bal LC, Pfefferle S, Unger S, Hoffmann C, Berzow D, Kohsar M, Aepfelbacher M, Lohse AW, Addo MM, Lütgehetmann M, Schulze Zur Wiesch J, Schmiedel S. Hermanussen L, et al. J Med Virol. 2023 Jan;95(1):e28181. doi: 10.1002/jmv.28181. Epub 2022 Oct 20. J Med Virol. 2023. PMID: 36177717 No abstract available.